PACKAGE LEAFLET: INFORMATION FOR THE USER. <Amlodipine 5 mg and 10 mgtablets> Amlodipine maleate
|
|
- Arthur Harris
- 6 years ago
- Views:
Transcription
1 PACKAGE LEAFLET: INFORMATION FOR THE USER <Amlodipine 5 mg and 10 mgtablets> Amlodipine maleate Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What <Amlodipine> is and what it is used for 2. Before you take <Amlodipine> 3. How to take <Amlodipine> 4. Possible side effects 5. How to store <Amlodipine> 6. Further information 1. WHAT <AMLODIPINE> IS AND WHAT IT IS USED FOR <Amlodipine> belongs to a group of drugs called calcium-channel blockers. It relieves heart problems by widening blood vessels to allow more blood to flow through. This helps to reduce blood pressure and relieve the strain on the heart muscle. <Amlodipine> is used to treat: - high blood pressure - various types of angina (chest pain), except unstable angina <Amlodipine Tablets> do not provide immediate relief of chest pain from angina. 2. BEFORE YOU take <Amlodipine> Do not take <Amlodipine> if you: - are allergic (hypersensitive) to <Amlodipine> or any other ingredients of the medicine - are allergic (hypersensitive) to any other calcium channel blockers e.g. nifedipine, felodipine - are suffering from shock (including shock induced by a heart condition) - have very low blood pressure - suffer from aortic stenosis (a narrowing of the main artery leading from the heart) - have suffered from heart failure following a heart attack. If you are not sure whether any of the above applies to you, ask your pharmacist or your doctor. Take special care with <Amlodipine> Tell your doctor before you start to take this medicine if you: - have any liver problems - have heart failure. Children Safety and effectiveness have been studied in 6-17-year-old boys and in girls. <Amlodipine> has not been studied in children under the age of 6 years. For more information, talk to your doctor. NL-H PL.doc / Version 1.2 December
2 Taking other medicines Some medicines (including medicines obtained without prescription, herbal medications or natural products) may interact with <Amlodipine>. This means that the action of both medicines can be changed. It is therefore important to tell your doctor if you take any of the following medicines: - Medicines that can lower blood pressure, e.g. beta blockers, ACE inhibitors, alpha-1 blockers and diuretics. Amlodipine may enhance the blood pressure-lowering effects of these medicines. - Diltiazem (heart medicine) may intensify the effect of amlodipine. - Ketoconazole and itraconazole (antifungal medicines) may intensify the effect of amlodipine. - HIV protease inhibitors (antiviral medicines to treat HIV infections, e.g. ritonavir) may intensify the effect of amlodipine. - Erythromycin (an antibiotic) may intensify the effect of amlodipine. - Rifampicin (an antibiotic) may reduce the effect of amlodipine. - St. John s wort (Hypericum perforatum; herbal medicine for depression) may reduce the effect of amlodipine. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding Do not take <Amlodipine> if you are pregnant or trying to become pregnant. <Amlodipine> should only be used during pregnancy if your doctor decides that it is absolutely necessary. There is no information on the use of <Amlodipine> during breast-feeding. If it is essential that you continue taking <Amlodipine>, then you should stop breast-feeding during treatment. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Taking <Amlodipine> may cause dizziness, headache, fatigue or nausea. Do not drive or operate machinery if you are affected. 3. HOW TO TAKE <AMLODIPINE> Always take <Amlodipine> Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The tablets should be swallowed preferably with a glass of water. The usual dose is: Adults The starting dose is one 5 mg tablet, once a day. Your doctor may increase this, after 2-4 weeks, to a maximum of 10 mg once a day. Elderly patients There is no special dosage for the elderly; however, care must be taken when the dose is increased. If you have kidney problems The normal dosage is recommended. Amlodipine cannot be removed from the blood by dialysis (artificial kidney). <Amlodipine> should be administered with particular caution to patients NL-H PL.doc / Version 1.2 December
3 undergoing dialysis. If you have liver problems The exact dose needed for patients with liver problems has not been determined. If you have liver problems, <Amlodipine> should be used very carefully (see also the section Take special care with <Amlodipine> ). Children For children (6-17 years old), the recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. Amlodipine 2.5 mg is not currently available and the 2.5 mg dose cannot be obtained with <Amlodipine> 5 mg as these tablets are not manufactured to break into two equal halves. If you take more <Amlodipine> than you should If you (or someone else) swallow a lot of the tablets all together, or if you think a child has swallowed any of the tablets, contact your doctor or go to your nearest hospital casualty department immediately. An overdose is likely to cause severe low blood pressure. Please take this leaflet, any remaining tablets and the container with you to the hospital or doctor so that they know which tablets were consumed. The person concerned should be made to lie down with their arms and legs up (resting on a couple of cushions, for example). Symptoms of an overdose are extreme dizziness and/or feeling very light-headed, problems with breathing, having to urinate very often. If you forget to take <Amlodipine> If you forget to take a tablet, take one as soon as you remember, unless it is nearly time to take the next one. Do not take a double dose to make up for a forgotten dose. Take the remaining doses at the correct time. If you stop taking <Amlodipine> Do not stop taking your medicine without talking to your doctor first even if you feel better. If you stop treatment suddenly, your symptoms may come back. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, <Amlodipine> can cause side effects, although not everybody gets them. If the following happens, stop taking the tablets and tell your doctor immediately or go to the casualty department at your nearest hospital: - an allergic reaction (swelling of the lips, face or neck leading to severe difficulty in breathing; hives, mild to more severe skin rashes that may involve blistering and peeling of the skin). This is a very serious but rare side effect. You may need urgent medical attention or hospitalisation. The following side effects have been reported at the approximate frequencies shown: Common (affecting one to 10 users in 100): - sleepiness - headaches (especially at the beginning of treatment) - feeling hot or becoming flushed in the face - nausea - tiredness - dizziness NL-H PL.doc / Version 1.2 December
4 - stomach ache - swelling of the ankles or limbs. Uncommon (affecting one to 10 users in 1,000): - runny and itchy nose - a general feeling of being unwell - increased sweating - dry mouth, change in or loss of the sense of taste - shortness of breath - sleeplessness - problems with sight - ringing in the ears - mood changes including anxiety, depression - abnormal heart rate - low blood pressure (feeling dizzy or faint) - altered or increased need to pass water, including during the night - vomiting - pain in the joints or muscles - hair loss - diarrhoea or constipation - indigestion - pain, including in the back or chest - trembling or shaking - enlargement of the breasts in men - increase or decrease in weight - impotence - skin rash and pruritus (itchy skin) - skin discolouration, purple skin patches - muscle cramps - numbness or a tingling sensation of the skin - fainting - lack of energy, physical weakness. Rare (affecting one to 10 users in 10,000): - confusion. Very rare (affecting fewer than one user in 10,000): - allergic reactions including swelling of the face and throat - allergic skin rash with irregular red spots, caused by medicines (erythema exsudativum multiforme), itchy rash, severe allergic reactions with blistering eruptions of the skin and mucous membranes (exfoliative dermatitis, Stevens-Johnson syndrome) - sensitivity of the skin to light - increased blood sugar levels, which may be experienced as an increase in appetite or thirst - inflammation of the stomach lining resulting in persistent stomach pain, indigestion and flatulence - inflammation of the pancreas, which causes severe pain in the abdomen and back - swollen gums - jaundice (yellowing of the skin and whites of the eyes) - hepatitis (inflammation of the liver) - increased level of liver enzymes in the blood indicating liver problems - tense muscles - a disorder of the nerves which can cause weakness, pain, tingling or numbness - unusual bleeding or unexplained bruising - a blood disorder which may be characterised by fever, chills, a sore throat or ulcers in the mouth or throat - inflammation of the blood vessels, which may produce purplish spots on the skin that do not turn white when pressed NL-H PL.doc / Version 1.2 December
5 - cough - heart attack, irregular heartbeat. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE <AMLODIPINE> Keep out of the reach and sight of children. Do not store above 25 C. Store in the original package in order to protect from light and moisture. Do not use <Amlodipine> after the expiry date that is stated on the outer packaging. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What <Amlodipine Tablets > contain - The active ingredient is amlodipine (as maleate). - The other ingredients are microcrystalline cellulose, anhydrous calcium hydrogen phosphate, sodium starch glycolate and magnesium stearate. What <Amlodipine Tablets > look like and contents of the pack - The 5 mg tablets are white, oval-shaped tablets with AM 5 on one side, plain on the other side. They are available in pack sizes* of 20, 28, 30, 50, 100, 200 and 300 tablets. - The 10 mg tablets are white, oval shaped tablets with AM 10 and a breakline on one side, plain on the other side. The tablets can be divided into equal halves. They are available in pack sizes* of 14, 20, 28, 30, 50, 100, 200 and 300 tablets. *Not all pack sizes may be marketed. Marketing Authorisation Holder <To be completed nationally> Manufacturer <To be completed nationally> Pharmachemie B.V., Swensweg 5, Postbus 552, 2003 RN Haarlem, the Netherlands OR TEVA UK Ltd, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom OR Oy Galena Ltd, Sammonkatu 10, P.O. Box 1450, Kuopio, Finland OR Teva Pharmaceutical Works Private Limited Company, Pallagi út 13, 4042 Debrecen, Hungary This medicinal product is authorised in the Member States of the EEA under the following names: Germany: Italy: Netherlands: Spain: Amlo-TEVA 5 mg & 10 mg Tabletten Amlodipina Teva 5 mg & 10 mg Compresse Amlodipine 5 mg & 10 mg Pharmachemie; tabletten Amlodipino Teva 5 mg & 10 mg comprimidos EFG NL-H PL.doc / Version 1.2 December
6 United Kingdom: Amlodipine 5 mg & 10 mg Tablets Marketing Authorisation Number: This leaflet was last revised in: December NL-H PL.doc / Version 1.2 December
PATIENT INFORMATION LEAFLET AMLOC RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin
PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Famciclovir Teva 250 mg Film-coated Tablets. Famciclovir 125, 250 & 500 mg Film-coated Tablets.
PACKAGE LEAFLET: INFORMATION FOR THE USER Famciclovir Teva 125 mg Film-coated Tablets Famciclovir Teva 250 mg Film-coated Tablets Famciclovir Read all of this leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationLovastatin tablets 20 and 40 mg PACKAGE LEAFLET
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Lovastatin Mylan 20 mg Tablets Lovastatin Mylan 40 mg Tablets lovastatin Read all of this leaflet carefully before you start taking this medicine.
More informationATORIS 10, 20, 40 mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the user. Anastrozole Teva 1 mg Film-coated Tablets Anastrozole
Package leaflet: Information for the user Anastrozole Teva 1 mg Film-coated Tablets Anastrozole Read all of this leaflet carefully before you start taking this medicine because it contains improtant information
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this
More informationPATIENT INFORMATION LEAFLET CARZIN XL
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: 4 mg film coated tablets. Read all of this leaflet carefully before you start taking. Keep this leaflet. You may need to read it
More informationPackage leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin
Package leaflet: Information for the user Dalmevin 50 mg tablets Vildagliptin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET DYNARB RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNARB 75 mg tablets DYNARB 150 mg tablets DYNARB 300 mg tablets Read all of this leaflet carefully before you start taking DYNARB.
More informationWhat is in this leaflet
Package leaflet: Information for the user 2.5 mg film-coated tablets Naratriptan Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationSibelium 5 mg Tablets flunarizine
J-C 2017 Sibelium 5 mg Tablets flunarizine PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol
Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationIt does not take the place of talking to your doctor or pharmacist.
ZOMIG Zolmitriptan Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about Zomig. It does not contain all the information that is known
More informationAciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir
Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. <Product name> 5 mg tablets <Product name> 10 mg tablets Amlodipine maléate
FL HU, SK, LU, NL, LV, BE, AT PACKAGE LEAFLET: INFORMATION FOR THE USER 5 mg tablets 10 mg tablets Read all of this leaflet carefully before you start taking this medicine.
More informationPackage leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)
PACKAGE LEAFLET Package leaflet: Information for the user Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) Read all of this leaflet carefully before you start taking this medicine because
More informationAciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir
Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET TEXAMER
SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,
More informationPackage leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine
Package leaflet: Information for the patient Felodipin AstraZeneca 2.5 mg prolonged-release tablets Felodipin AstraZeneca 5 mg prolonged-release tablets Felodipin AstraZeneca 10 mg prolonged-release tablets
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets Lercanidipine hydrochloride Read all of this leaflet carefully before you start
More informationPackage leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe
Package leaflet: Information for the user Ezetimibe STADA 10 mg, tabletten Ezetimibe Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg Tablets sodium fusidate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: information for the user. Tevanate Once Weekly 70 mg Tablets Alendronic acid
Package leaflet: information for the user Tevanate Once Weekly 70 mg Tablets Alendronic acid Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)
Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide
Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationRead all of this leaflet carefully before you start taking this medicine.
Package Leaflet: Information for the User Tamoxifen 10mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If
More information1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationKAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationMotens 2 mg and 4 mg Tablets lacidipine
Package leaflet: Information for the user Motens 2 mg and 4 mg Tablets lacidipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride Read all of this leaflet carefully before you start using this
More information1. What Betahistine dihydrochloride tablets is and what it is used for
Package leaflet: Information for the user Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start
More informationPatient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol
Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this
More informationRANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationPHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET
PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL
More informationRead all of this leaflet carefully before you start taking this medicine.
Moxelle 20mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor
More informationSanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets
Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Pizotifen (as malate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it
More informationPackage leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine
Package leaflet: Information for the user Tetrabenazine 25 mg tablets tetrabenazine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)
Package leaflet: Information for the user Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationSome general information on hepatitis A infection is given at the end of this leaflet.
Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before
More informationPATIENT INFORMATION LEAFLET POLLENTYME S AND TABS
SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information
More informationFlecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.
1 Consumer Medicine Information Flecainide acetate Tablets 50 mg & 100 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions
More informationPackage leaflet: Information for the patient. Amlode 5 mg Tablets Amlode 10 mg Tablets. amlodipine
Package leaflet: Information for the patient Amlode 5 mg Tablets Amlode 10 mg Tablets amlodipine Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationIf you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.
PACKAGE LEAFLET: Information for the user Letrozole 2.5 mg Film-coated Tablets Letrozole Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage Leaflet: Information for the User. Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan
Package Leaflet: Information for the User Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir
Package leaflet: Information for the user Famvir 125, 250 and 500 mg film-coated tablets famciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Doxazosin 1, 2, 4 mg tablets Doxazosin mesilate
PACKAGE LEAFLET: INFORMATION FOR THE USER Doxazosin 1, 2, 4 mg tablets Doxazosin mesilate Read all of this leaflet carefully before you start taking/using this medicine. Keep this leaflet. You may need
More information2 What you need to know before you take Zantac
Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Tipuric 100 & 300 mg Tablets Allopurinol
PACKAGE LEAFLET: INFORMATION FOR THE USER Tipuric 100 & 300 mg Tablets Allopurinol Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Anastrozole 1 mg film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE
PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin HCl Ranbaxy 10 mg tablets, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before using this medicine. - Keep this
More informationHERNOVIR 200 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPackage leaflet: Information for the user. ISTIN 5 mg and 10 mg tablets. Amlodipine
Package leaflet: Information for the user ISTIN 5 mg and 10 mg tablets Amlodipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.
Package leaflet: Information for the patient Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets Torasemide Read all of this leaflet carefully before you start taking
More informationPackage leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril)
Package leaflet: Information for the patient Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril) Read all of this leaflet carefully before you start taking this medicine
More informationLISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate
LISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate WHAT IS IN THIS LEAFLET This leaflet answers some common questions about LISINOPRIL-GA. It does not contain all the available information.
More informationPOLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS
PROPOSED FINAL PATIENT INFORMATION LEAFLET FOR POLLENTYME TABLETS & POLLENTYME S PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS
More informationPATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate
PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine)
PACKAGE LEAFLET: INFORMATION FOR THE USER Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine) Read all of this leaflet carefully before you start using this medicine.
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationPackage Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)
Novartis (logo) Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate) Read all of this leaflet carefully before you start taking this medicine
More informationNeurostil 100 mg Capsules Neurostil 300 mg Capsules Neurostil 400 mg Capsules. Gabapentin
PACKAGE LEAFLET: INFORMATION FOR THE USER Neurostil 100 mg Capsules Neurostil 300 mg Capsules Neurostil 400 mg Capsules Gabapentin Read all of this leaflet carefully before you start taking this medicine.
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Aciclovir 200 mg Tablets 1 Aciclovir Read all of this leaflet carefully before you start taking this medicine.
More informationPackage leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine
Package leaflet: Information for the patient Histaclar 10 mg Film-coated Tablets loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin
PATIENT INFORMATION LEAFLET ZITHROMAX 250mg Capsules azithromycin Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you have
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: information for the user. Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets Sildenafil
Package leaflet: information for the user Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets Sildenafil Read all of this leaflet carefully before you start taking this medicine because it contains
More information1. What Solpadol is and what it is used for
PATIENT INFORMATION LEAFLET SOLPADOL 30mg/500mg CAPLETS Codeine Phosphate and Paracetamol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPackage leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate
PACKAGE LEAFLET Package leaflet: Information for the patient Calcium Folinate 15 mg Tablets calcium folinate Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin
Package leaflet: Information for the user Floxapen 250 mg & 500 mg Capsules Flucloxacillin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen
PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationEpiramat 25mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Epiramat 25mg Film-coated Tablets TOPIRAMATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET CRESTOVAS (ROSUVASTATIN 5MG, 10MG, 20MG & 40MG, TABLETS USP) Please read this leaflet carefully before you start to take your medicine. It contains important information. Keep
More informationPackage leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan
Package leaflet: Information for the user Zomig 2.5 mg tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep
More informationPackage leaflet: Information for the user. Burinex 5 mg Tablets bumetanide
Package leaflet: Information for the user Burinex 5 mg Tablets bumetanide Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep
More informationPackage leaflet: Information for the patient. Atorvastatin Krka 40 mg film-coated tablets. Atorvastatin
PACKAGE LEAFLET Package leaflet: Information for the patient Atorvastatin Krka 10 mg film-coated tablets Atorvastatin Krka 20 mg film-coated tablets Atorvastatin Krka 40 mg film-coated tablets Atorvastatin
More informationPackage leaflet: Information for the user. Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole
Package leaflet: Information for the user Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe
Package leaflet: Information for the patient Ezetimibe 10 mg tablets ezetimibe Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)
PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationConsumer Medicine Information. This leaflet answers some common questions about Calvasc tablets
Consumer Medicine Information Calvasc Tablets Amlodipine 5 mg tablets and 10 mg tablets What is in this leaflet This leaflet answers some common questions about Calvasc tablets It does not contain all
More informationMETHYLDOPA 250 mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 4 mg chewable tablets Read all of this leaflet carefully before your child starts taking this medicine. Keep this leaflet. You may need to read it again.
More informationPackage Leaflet: Information For The User Cilostazol Evolan 100 mg tablets Cilostazol
Package Leaflet: Information For The User Cilostazol Evolan 100 mg tablets Cilostazol This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil
PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationIrbenida H 150mg/12,5mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More information